BridgeMD
New treatment option for Hypoglycemia Non-Diabetic
Official title Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery
ClinicalTrials.gov ID: NCT06468865
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if continuous glucose monitoring works to treat postprandial hypoglycaemia in patients who have undergone gastric bypass surgery. The main question it aims to answer is: Is continuous glucose monitoring superior to usual care for prevention of postprandial hypoglycaemia in patients with verified postprandial hypoglycaemia after gastric bypass surgery?
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Gastric bypass surgery at least 1 year ago
- Age ≥18 years
- Symptomatic postprandial hypoglycaemia; capillary glucose level \<3.0 mmol/L 1-4 hours after meals
You likely can't join if
- Not able to give informed consent
- Reduced compliance due to severe mental and psychiatric conditions
- Use of insulin or sulfonylureas
- Use of systemic corticosteroids
- Primary or secondary adrenal insufficiency
- Insulinoma
See the full eligibility criteria
- Gastric bypass surgery at least 1 year ago
- Age ≥18 years
- Symptomatic postprandial hypoglycaemia; capillary glucose level \<3.0 mmol/L 1-4 hours after meals
- Not able to give informed consent
- Reduced compliance due to severe mental and psychiatric conditions
- Use of insulin or sulfonylureas
- Use of systemic corticosteroids
- Primary or secondary adrenal insufficiency
- Insulinoma
- Severe heart-, lung, liver- or kidney disease, cancer, malnutrition and other medical conditions causing fragility
- Performed bariatric revisional surgery
- Drug- or alcohol abuse
- Pregnancy
- Use of acarbose or octreotide in the treatment of postprandial hypoglycemia
- Use of continuous glucose monitor
The study team makes the final eligibility decision.
Where it's taking place
- Tønsberg, Vestfold, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tønsberg, Vestfold, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.